s/p catalysts:, page-10

Timbooooo, at the moment they sell Baby Nappies in Japan.

Their stock price might rocket if there is a sudden overnight spike in the Japanese birth rate.

I'm not even sure if the Nappies are eco friendly, the business sure as hell is not profitable, which is why they jumped on to the Cynata opportunity.

They have given themselves 18 months to mop up all the Cynata shares, though Cynata hope it is sooner.

Meanwhile Cynata progress with their animal studies into blood vessel regeneration via allogeneic stem cells derived for diabetes treatments.

This will be a long term investment, and as such, it may ride a wave of global research into stem cell and regenerative medicine over the next 5 years.

Highly speculative, scientifically fascinating.

A number of things might help the stock price in the medium term.
1. Successful takeover of all Cynata shares.
2. Rebranding of the company, new medical directors, roadshows etc... after the takeover.
3. Successful initial animal trials of Cynata's technology.
4. Receiving the grant applied for in the USA.
5. Listing on the Nasdaq (or in the USA, after the takeover).
6. Cornerstone investor coming on board (perhaps an established stem cell company who wants to cover all the bases, because Cynata has a global patent pending on it's mesenchymoangioblast (MCA) based therapeutics technology).

Gw